Israeli Life Sciences Boom; Exchange Draws Flood of IPOs; Some see Symptoms of a Bubble
WSJ -- Appetite for Israeli initial public offerings of life-science companies is booming, but critics say the sector is immature and lacks the transparency for investors to make informed decisions.
The first three months of 2011 have brought four life-sciences IPOs, and several more are planned for the first half of the year. The rate so far has been far ahead of that of the past three years, with only four IPOs in all of 2010, one in 2009 and none in 2008.